OKRA Technologies
Acquisition in 2023
OKRA Technologies is an artificial intelligence data analytics company focused on enhancing the healthcare sector through its innovative platform. This platform enables healthcare professionals to integrate multiple complex data sets, generating real-time evidence-based insights that aim to improve patient outcomes and inform critical decision-making. Users can interact with the data through a user-friendly search interface, posing natural language questions to receive actionable insights swiftly. OKRA's advanced algorithms also facilitate the prediction of future outcomes, allowing healthcare providers to make informed and efficient choices. The company has applied its technology in various contexts, including clinical trials and social services, to optimize treatment strategies and resource allocation.
doDOC is a Boston-based company founded in 2015 by MIT alumni, specializing in a flexible cloud-based document editor that enhances team collaboration. The platform allows multiple users to work on the same document simultaneously, significantly speeding up the planning, drafting, editing, reviewing, and approval processes by over 70%. With an emphasis on well-governed workflows and granular permissions, doDOC provides a comprehensive audit trail for every document, catering to teams with varying roles and responsibilities. Its user-friendly design simplifies the writing and management experience, effectively automating technical aspects that can hinder productivity. Suitable for businesses of all sizes, from startups to multinational corporations, doDOC aims to transform the content collaboration landscape by streamlining workflows and facilitating real-time collaboration without the complexity of multiple systems.
Two Labs
Acquisition in 2020
Two Labs is a prominent pharmaceutical services company specializing in consultancy for the pharmaceutical and biotechnology sectors. It offers a comprehensive range of services, including market access, market intelligence, and commercialization support. With experience in leading over 200 new product launches and managing more than 290 in-market projects, Two Labs assists pharmaceutical manufacturers in navigating the complexities of the product lifecycle. The company's expertise encompasses strategic consulting, lifecycle management, and acquisition transition, allowing clients to effectively address challenges from strategy development to implementation.
90 Ten
Acquisition in 2020
90TEN is an independent healthcare communications consultancy.
Touch Creative Design
Acquisition in 2017
Touch Creative Design is a Pharma/Healthcare focused agency with multi-industry experience – predominantly healthcare focused they also work across other industries. This experience keeps their ideas fresh, allowing them to evaluate and experiment with the latest technologies and learn what works with respect to customer engagement. Specialties include: Creative strategy development; Digital & technology-based experiences; Exhibitions and Event services; Branding and traditional creative media.
Alligent Biopharm Consulting
Acquisition in 2015
Alligent Biopharm Consulting LLC is a medical affairs-focused agency based in Stirling, New Jersey, established in 2009. The company specializes in developing and delivering integrated medical communications solutions tailored for the biopharmaceutical industry. Its comprehensive range of services includes medical strategy development, stakeholder support, impact analytics, and various forms of content creation. Alligent's expertise encompasses clinical trial design, competitor assessment, thought leader engagement, and market intelligence. The agency also provides internal training, conference intelligence, and social media analysis. Operating under a contract platform, Alligent ensures timely and budget-conscious delivery of data and insights, facilitating effective communication and strategic planning within the medical affairs landscape. As of September 2015, Alligent Biopharm Consulting LLC is a subsidiary of Envision Pharma, Inc.
ProScribe
Acquisition in 2014
ProScribe is a company that was acquired by Envision Pharma Group in 2014.